Cilostazol Lowers Death Risk in Diabetic PAD Patients
1Korean study finds drug effective for diabetic leg artery disease.
2Cilostazol reduces mortality and prevents severe limb complications.
3It protects blood vessels without increasing bleeding risks for seniors.
📖 Easy Explanation
🔍 Background
Long-term diabetes damages blood vessels, leading to Peripheral Artery Disease (PAD), which can result in limb loss. Doctors have long sought the safest and most effective treatment for these patients.
📌 Key Points
A study of over 14,000 patients for 5 years found that those taking Cilostazol had a lower risk of death. It also significantly reduced the risk of needing surgery due to re-blocked leg arteries.
💡 Why It Matters
This is hopeful news for seniors with diabetes who experience leg numbness or pain while walking. Since it has a low risk of bleeding, consulting a doctor about this medication could help protect leg health.
📚 Glossary
PAD (Malcho Dongmaek Jilhwan)Peripheral Artery Disease where leg vessels narrow or block, causing pain and necrosis.
실로스타졸 (Silostazol)An antiplatelet medication that helps blood circulation and dilates blood vessels.
MALEs (Haji Juyo Sageon)Major Adverse Limb Events, such as amputation or the need for emergency surgery.
코호트 연구 (Cohort Yeongu)A research method that observes a specific group over time to identify disease causes or drug efficacy.